Plan: OPEN | Option: Dividend | Meeta Shetty

15 Jan 21 | 12:00 AM

15.26 -0.16 (-1.03%)

  • Outperforms

    61.93%

    Return (1Y)

    beaten Nifty Pharma TRI by 7.85%

  • Less Volatile

    1.62%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.49%

  • Not so consistent

    6/12

    Months

    Has beaten Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Tata India Pharma & Healthcare Fund (D), has beaten by 7.85% (CAGR difference)

61.93%

Outperforms

This is Alpha

Performance Chart for Rs

Invested in

Risk

In last 1 year , the volatility of Tata India Pharma & Healthcare Fund (D) is Lower than by -0.49%

1.62%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 6 out of Last 12 Months, i.e 50% of the times It beaten its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition